(Q48725607)

15 February 2018

title

Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain (English)

1 reference

15 February 2018

1 reference

Sills GJ

1

1 reference

15 February 2018

Leach JP

2

1 reference

15 February 2018

Fraser CM

3

1 reference

15 February 2018

Forrest G

4

1 reference

15 February 2018

Patsalos PN

5

1 reference

15 February 2018

Brodie MJ

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 February 2018

European Journal of Pharmacology

published in

1 reference

15 February 2018

volume

325

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

35-40

1 reference

15 February 2018

Mechanisms of action of antiepileptic drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

High-performance liquid chromatographic analysis of neurotransmitter amino acids in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Assay for aliphatic amino acid decarboxylases by high-performance liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Neurochemical actions of gabapentin in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Progress report on new antiepileptic drugs. A summary of the Second Eilat Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

GABA-transaminases of human brain and peripheral tissues--kinetic and molecular properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

Adaptation of an enzymatic fluorescence assay for L-glutamic acid decarboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900105-2

10.1016/S0014-2999(97)00105-2

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018